Skip to main content
. 2023 Feb 9;14:23. doi: 10.1186/s13287-022-03234-y

Table 2.

Adverse events of safety outcomes between groups

Treatment group Control group
Severe adverse events
Seizure 1 0
Urinary tract infection 0 0
Pneumonia 0 0
Influenza 0 0
Death 0 0
Other adverse events
Otitis media acute 0 0
Nasal mucosa hemorrhage 1 0
Conjunctival irritations 0 0
Constipation 0 0
Dyspepsia 0 0
Nausea, vomiting 0 0
Diarrhea 0 0
Colitis 0 0
Anorexia 0 0
Herpangina 0 0
Fever 2 0
Febrile convulsion 0 0
Irritability 0 0
Insomnia 0 0
Bronchitis 0 0
Hypoxia 0 0
Dermatitis 0 0
Urticaria 0 0
Hirsutism 0 0
Alopecia 0 0